These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 7270565)
41. Cautions on the use of vitamin K and enteral preparations. Kutsop JJ Am Pharm; 1983 Oct; NS23(10):16-7. PubMed ID: 6637790 [No Abstract] [Full Text] [Related]
42. An unrecognized cause of warfarin resistance. Westfall LK Drug Intell Clin Pharm; 1981 Feb; 15(2):131. PubMed ID: 7274023 [No Abstract] [Full Text] [Related]
43. [Determination of susceptibility level of Mus musculus and Rattus flavipectus to warfarin]. Deng Z Zhonghua Yu Fang Yi Xue Za Zhi; 1982 Nov; 16(6):345-7. PubMed ID: 7166077 [No Abstract] [Full Text] [Related]
44. [Experimentally induced increased tolerance to warfarin in the domestic mouse (Mus musculus)]. Tannert W Monatsh Veterinarmed; 1976 Dec; 31(23):895-9. PubMed ID: 1012273 [No Abstract] [Full Text] [Related]
45. Increasing prothrombin times in a warfarin-treated patient upon withdrawal of ensure plus. Griffith LD; Olvey SE; Triplett WC Crit Care Med; 1982 Nov; 10(11):799-800. PubMed ID: 7140325 [No Abstract] [Full Text] [Related]
46. Rectification on drug interactions with warfarin. Osmundson PJ; Rosenow EC; Brown ML Mayo Clin Proc; 1981 May; 56(5):339. PubMed ID: 7230898 [No Abstract] [Full Text] [Related]
47. Unifactorial inheritance of warfarin resistance in Rattus norvegicus from Denmark. Greaves JH; Ayres PB Genet Res; 1977 Jun; 29(3):215-22. PubMed ID: 892442 [No Abstract] [Full Text] [Related]
48. Warfarin and azathioprine: a drug interaction does exist. Rivier G; Khamashta MA; Hughes GR Am J Med; 1993 Sep; 95(3):342. PubMed ID: 8368235 [No Abstract] [Full Text] [Related]
49. Warfarin and azathioprine: an important drug interaction. Singleton JD; Conyers L Am J Med; 1992 Feb; 92(2):217. PubMed ID: 1543209 [No Abstract] [Full Text] [Related]
50. Warfarin resistance: a balanced polymorphism in the Norway rat. Greaves JH; Redfern R; Ayres PB; Gill JE Genet Res; 1977 Dec; 30(3):257-63. PubMed ID: 606626 [No Abstract] [Full Text] [Related]
51. High clearance of (S)-warfarin in a warfarin-resistant subject. Hallak HO; Wedlund PJ; Modi MW; Patel IH; Lewis GL; Woodruff B; Trowbridge AA Br J Clin Pharmacol; 1993 Mar; 35(3):327-30. PubMed ID: 8471414 [TBL] [Abstract][Full Text] [Related]
52. Clinically significant drug interactions with the oral anticoagulants. Freedman MD; Olatidoye AG Drug Saf; 1994 May; 10(5):381-94. PubMed ID: 8037888 [TBL] [Abstract][Full Text] [Related]
53. Reversal of osmolite-warfarin interaction by changing warfarin administration time. Petretich DA Clin Pharm; 1990 Feb; 9(2):93. PubMed ID: 2106407 [No Abstract] [Full Text] [Related]
54. Inhibition of the hypoprothrombinemic effect of warfarin (Coumadin) by Ensure Plus, a dietary supplement. Michaelson R; Kempin SJ; Navia B; Gold JW Clin Bull; 1980; 10(4):171-2. PubMed ID: 7214706 [No Abstract] [Full Text] [Related]
55. Liquid nutrition as a cause of warfarin resistance. Zallman JA; Lee DP; Jeffrey PL Am J Hosp Pharm; 1981 Aug; 38(8):1174. PubMed ID: 7270565 [No Abstract] [Full Text] [Related]
56. Warfarin resistance linked to enteral nutrition products. Howard PA; Hannaman KN J Am Diet Assoc; 1985 Jun; 85(6):713-5. PubMed ID: 3998343 [No Abstract] [Full Text] [Related]